Robert L. Nussbaum, Chief Medical Officer at Invitae Corp (NVTA), sold 45,793 shares at $33.86 ($1.5M) on 2020-09-10, disclosed to the SEC on 2020-09-14.
Open-market sale of $1.5M NVTA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.97 | 9,391 | $310K | 20.1% |
| 2 | $32.97 | 9,391 | $310K | 20.1% |
| 3 | $33.86 | 11,497 | $389K | 25.3% |
| 4 | $33.86 | 11,497 | $389K | 25.3% |
| 5 | $33.87 | 557 | $19K | 1.2% |
| 6 | $34.69 | 1,730 |
| $60K |
| 3.9% |
| 7 | $34.69 | 1,730 | $60K | 3.9% |
| Total | $33.56 avg | 45,793 | $1.5M | 100% |
| Filing → |
| NVTA | SELL | 2023-03-15 | $4K | — | Filing → |
| NVTA | SELL | 2022-08-18 | $32K | — | Filing → |
| NVTA | SELL | 2022-05-19 | $23K | — | Filing → |